title: Non-Radiographic Axial Spondyloarthritis.
abstract: The term non-radiographic axial spondyloarthritis (nrAxSpA) was coined for patients who have a clinical picture of ankylosing spondylitis (AS) but do not exhibit radiographic sacroiliitis. The ASAS classification criteria for nrAxSpA, ensuring the recruitment of homogenous study cohorts, were accepted in 2009, although the respective diagnostic criteria for daily clinical practice have not yet been developed. The clinical diagnosis should be based on the composite of clinical symptoms and signs of the disease, HLA B27 status, and magnetic resonance imaging (MRI) of sacroiliac joints. Notably, a negative MRI or HLA B27 does not exclude the diagnosis in patients with a high clinical suspicion for nrAxSpA. The prevalence of nrAxSpA is similar to that of AS, but the former has a higher female preponderance. The rate of progression of nrAxSpA to the radiographic stage of disease (AS) ranges from 10% to 20% over 2 years. Current treatment strategies for nrAxSpA are the same as for AS and include non-steroidal anti-inflammatory drugs and inhibitors of tumor necrosis factor-alpha. While this review summarizes the current achievements in the field of nrAxSpA, further understanding of the epidemiology and natural history of the disease and, particularly, mechanisms of inflammation and subsequent new bone formation is essential for the development of new treatment strategies for nrAxSpA patients.
authors.forename: Gleb
authors.initials: G
authors.lastname: Slobodin
authors.forename: Iris
authors.initials: I
authors.lastname: Eshed
mesh_terms: D018450:Disease Progression; D005260:Female; D015796:HLA-B27 Antigen / Q000032:analysis; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D015995:Prevalence; D012446:Sacroiliac Joint / Q000473:pathology; D012737:Sex Factors; D025241:Spondylarthritis / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology*; D013167:Spondylitis, Ankylosing / Q000175:diagnosis* / Q000188:drug therapy
chemical_list: D015796:HLA-B27 Antigen